Simon Mucha
Overview
Explore the profile of Simon Mucha including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
52
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Golbin J, Bui A, Philippone M, Ashton R, Mucha S
Chest
. 2024 Oct;
166(4):e105-e108.
PMID: 39389690
A 71-year-old man with a history of recurrent tonsillar squamous cell carcinoma was admitted to the hospital with oropharyngeal bleeding. He received high-dose radiation therapy with curative intent. On day...
2.
Duggal A, Scheraga R, Sacha G, Wang X, Huang S, Krishnan S, et al.
BMJ Open
. 2024 Feb;
14(2):e079243.
PMID: 38320842
Objective: Conventional prediction models fail to integrate the constantly evolving nature of critical illness. Alternative modelling approaches to study dynamic changes in critical illness progression are needed. We compare static...
3.
Sohail M, Vachharajani T, Lane J, Huang S, Wang X, Mucha S, et al.
Crit Care Explor
. 2023 Dec;
5(12):e1023.
PMID: 38115819
Importance: Optimal blood product transfusion strategies before tunneled central venous catheter (CVC) placement are required in critically ill coagulopathic patients with liver disease to reduce exposure to allogeneic blood products...
4.
Gohar A, Kirupaharan P, Amaral V, Kokoczka L, Mireles-Cabodevila E, Mucha S, et al.
J Intensive Care Med
. 2023 Mar;
38(8):702-709.
PMID: 36883212
Prone position ventilation (PPV) is one of the few interventions with a proven mortality benefit in the management of acute respiratory distress syndrome (ARDS), yet it is underutilized as demonstrated...
5.
Sato R, Dugar S, Han X, Siuba M, Mucha S, Dettmer M, et al.
Shock
. 2022 Aug;
58(3):211-216.
PMID: 35959788
Objective: Several studies have shown septic shock developing later during the hospital stay is associated with higher mortality. However, the precise point at which time from hospital admission to the...
6.
Self W, Wheeler A, Stewart T, Schrager H, Mallada J, Thomas C, et al.
Chest
. 2022 Jul;
162(5):982-994.
PMID: 35780813
Background: Convalescent plasma has been one of the most common treatments for COVID-19, but most clinical trial data to date have not supported its efficacy. Research Question: Is rigorously selected...
7.
Bachelet T, Bourdenx J, Martinez C, Mucha S, Martin-Dupont P, Perier V, et al.
PLoS One
. 2021 Oct;
16(10):e0257646.
PMID: 34610031
Dialysis patients are both the most likely to benefit from vaccine protection against SARS-CoV-2 and at the highest risk of not developing an immune response. Data from the medical field...
8.
Self W, Stewart T, Wheeler A, El Atrouni W, Bistran-Hall A, Casey J, et al.
Trials
. 2021 Mar;
22(1):221.
PMID: 33743799
Background: Convalescent plasma is being used widely as a treatment for coronavirus disease 2019 (COVID-19). However, the clinical efficacy of COVID-19 convalescent plasma is unclear. Methods: The Passive Immunity Trial...
9.
Self W, Stewart T, Wheeler A, El Atrouni W, Bistran-Hall A, Casey J, et al.
Res Sq
. 2021 Mar;
PMID: 33688640
Convalescent plasma is being used widely as a treatment for coronavirus disease 2019 (COVID-19). However, the clinical efficacy of COVID-19 convalescent plasma is unclear. The Pass ive I mmunity T...
10.
Flegeau K, Rubin S, Mucha S, Bur P, Preterre J, Siadous R, et al.
Nephrol Dial Transplant
. 2019 May;
35(2):240-250.
PMID: 31121032
Background: The development of an artificial glomerular unit may be pivotal for renal pathophysiology studies at a multicellular scale. Using a tissue engineering approach, we aimed to reproduce in part...